Erytech announces trading resumption of its ordinary shares on Euronext Paris admERY November 10, 2017 Newsroom ERYTECH Pharma announces trading resumption of its ordinary shares on Euronext Paris as from 4:00pm CET. You Might Also Like ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia September 30, 2014 ERYTECH extends its cash horizon by implementing a convertible bond financing June 25, 2020 ERYTECH Presents New Data on GRASPA’s Mechanism of Action at ASH Annual Meeting December 1, 2016
ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia September 30, 2014
